ID   INP4A_RAT               Reviewed;         939 AA.
AC   Q62784;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 123.
DE   RecName: Full=Inositol polyphosphate-4-phosphatase type I A;
DE   AltName: Full=Inositol polyphosphate 4-phosphatase type I;
DE   AltName: Full=Type I inositol 3,4-bisphosphate 4-phosphatase;
DE            EC=3.1.3.66 {ECO:0000269|PubMed:7608176};
GN   Name=Inpp4a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF 22-48;
RP   245-248; 330-342; 494-504; 747-752; 755-781; 795-804 AND 927-939, TISSUE
RP   SPECIFICITY, CATALYTIC ACTIVITY, AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=7608176; DOI=10.1074/jbc.270.27.16128;
RA   Norris F.A., Auethavekiat V., Majerus P.W.;
RT   "The isolation and characterization of cDNA encoding human and rat brain
RT   inositol polyphosphate 4-phosphatase.";
RL   J. Biol. Chem. 270:16128-16133(1995).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Catalyzes the hydrolysis of the 4-position phosphate of
CC       phosphatidylinositol 3,4-bisphosphate (PubMed:7608176). Catalyzes also
CC       inositol 1,3,4-trisphosphate and inositol 1,4-bisphosphate
CC       (PubMed:7608176). Antagonizes the PI3K-AKT/PKB signaling pathway by
CC       dephosphorylating phosphoinositides and thereby modulating cell cycle
CC       progression and cell survival (By similarity). May protect neurons from
CC       excitotoxic cell death by regulating the synaptic localization of cell
CC       surface N-methyl-D-aspartate-type glutamate receptors (NMDARs) and
CC       NMDAR-mediated excitatory postsynaptic current (By similarity).
CC       {ECO:0000250|UniProtKB:Q9EPW0, ECO:0000269|PubMed:7608176}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol-3-phosphate) + phosphate; Xref=Rhea:RHEA:17193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57658,
CC         ChEBI:CHEBI:58088; EC=3.1.3.66;
CC         Evidence={ECO:0000269|PubMed:7608176};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17194;
CC         Evidence={ECO:0000305|PubMed:7608176};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 3,4-bisphosphate + H2O = 1D-myo-inositol 3-
CC         phosphate + phosphate; Xref=Rhea:RHEA:43388, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58401, ChEBI:CHEBI:83241;
CC         Evidence={ECO:0000269|PubMed:7608176};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43389;
CC         Evidence={ECO:0000305|PubMed:7608176};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,3,4-trisphosphate + H2O = 1D-myo-inositol
CC         1,3-bisphosphate + phosphate; Xref=Rhea:RHEA:43392,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58414,
CC         ChEBI:CHEBI:83242; Evidence={ECO:0000269|PubMed:7608176};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43393;
CC         Evidence={ECO:0000305|PubMed:7608176};
CC   -!- PATHWAY: Signal transduction; phosphatidylinositol signaling pathway.
CC       {ECO:0000269|PubMed:7608176}.
CC   -!- SUBUNIT: Interacts with INPP5F. {ECO:0000250|UniProtKB:Q96PE3}.
CC   -!- SUBCELLULAR LOCATION: Early endosome membrane
CC       {ECO:0000250|UniProtKB:Q96PE3}. Recycling endosome membrane
CC       {ECO:0000250|UniProtKB:Q96PE3}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q96PE3}. Nucleus {ECO:0000250|UniProtKB:Q96PE3}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q96PE3}. Postsynaptic density
CC       {ECO:0000250|UniProtKB:Q9EPW0}. Note=Translocates to the plasma
CC       membrane upon EGF stimulation (By similarity). Shuttles between the
CC       cytoplasm and the nucleus, depending on the cell cycle stage, with
CC       highest amounts detected in the nucleus during the G0/G1phase (By
CC       similarity). {ECO:0000250|UniProtKB:Q96PE3}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Alpha1;
CC         IsoId=Q62784-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha2;
CC         IsoId=Q62784-2; Sequence=VSP_015247;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at highest levels in
CC       the brain, heart and skeletal muscle. {ECO:0000269|PubMed:7608176}.
CC   -!- SIMILARITY: Belongs to the inositol 3,4-bisphosphate 4-phosphatase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U26397; AAB01069.1; -; mRNA.
DR   PIR; A57487; A57487.
DR   RefSeq; NP_112264.3; NM_031002.3.
DR   AlphaFoldDB; Q62784; -.
DR   SMR; Q62784; -.
DR   BioGRID; 249487; 1.
DR   STRING; 10116.ENSRNOP00000024330; -.
DR   SwissLipids; SLP:000000897; -.
DR   GlyGen; Q62784; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q62784; -.
DR   PhosphoSitePlus; Q62784; -.
DR   jPOST; Q62784; -.
DR   PaxDb; 10116-ENSRNOP00000024330; -.
DR   GeneID; 80849; -.
DR   KEGG; rno:80849; -.
DR   UCSC; RGD:68386; rat. [Q62784-1]
DR   AGR; RGD:68386; -.
DR   CTD; 3631; -.
DR   RGD; 68386; Inpp4a.
DR   eggNOG; KOG4428; Eukaryota.
DR   InParanoid; Q62784; -.
DR   OrthoDB; 5490552at2759; -.
DR   PhylomeDB; Q62784; -.
DR   BRENDA; 3.1.3.66; 5301.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-RNO-1855183; Synthesis of IP2, IP, and Ins in the cytosol.
DR   UniPathway; UPA00944; -.
DR   PRO; PR:Q62784; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0017161; F:inositol-1,3,4-trisphosphate 4-phosphatase activity; IEA:RHEA.
DR   GO; GO:0052828; F:inositol-3,4-bisphosphate 4-phosphatase activity; IEA:RHEA.
DR   GO; GO:0016316; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; IBA:GO_Central.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; ISO:RGD.
DR   CDD; cd04048; C2A_Copine; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR039034; INPP4.
DR   PANTHER; PTHR12187; AGAP000124-PA; 1.
DR   PANTHER; PTHR12187:SF4; INOSITOL POLYPHOSPHATE-4-PHOSPHATASE TYPE I A; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   PROSITE; PS50004; C2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Direct protein sequencing;
KW   Endosome; Hydrolase; Lipid metabolism; Membrane; Nucleus; Phosphoprotein;
KW   Reference proteome; Synapse.
FT   CHAIN           1..939
FT                   /note="Inositol polyphosphate-4-phosphatase type I A"
FT                   /id="PRO_0000190234"
FT   DOMAIN          26..153
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   ACT_SITE        857
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96PE3"
FT   MOD_RES         355
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96PE3"
FT   MOD_RES         488
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         575..585
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7608176"
FT                   /id="VSP_015247"
SQ   SEQUENCE   939 AA;  105589 MW;  1DC4B3F0A8F47D0D CRC64;
     MTAREHSPRH GARARAMQRA STIDVTADMV GLSLAGNIQD PDEPILEFSL ACSELHTPSL
     DRKPNSFVAV SVTTPPQAFW TKHAQTEIIE GTNNPIFLSS IAFFQDSLIN QMTQIKLSVY
     DVKDRSQGTM YLLGSGTFVV KDLLQDRHHR LHLTLRSAES DRVGNITVIG WQMEEKSDQQ
     PPVTRSLDTV NGRMVLPVDE SLTEALGIRS KYASLRKDSL LKAVFGGAIC RMYRFPTTDG
     NHLRILEQMA ESVLSLHVPR QFVKLLLEED AARVCELEEL GELSPCWESL RRQIVTQYQT
     IILTYQENLT DLHQYKGPSF KASSLKADKK LEFVPTNLHI QRMRVQDDGG SDQNYDVVTI
     GAPAAHCQGF KSGGLRKKLH KFEEAKKHSF EECCTSSTCQ SIIYIPQDVV RAKEIIAQIN
     TLKTQVSYYA ERLSRAAKDR SATGLERTLA ILADKTRQLV TVCDCKLLAN SIHGLNAARP
     DYIASKASPT STEEEQVMLR NDQDTLMARW AGRSSRSSLQ VDWHEEEWEK VWLNVDKSLE
     CIIQRVDKLL QKERLHGEGG EDVFPCSSTC SSKKDCSPPP EESCPGEWSE ALYPLLTTLT
     DCVAMMSDKA KAAMVFLLMQ TAAPTIASYL SLQYRRDVVF CQTLTALICG FIIKLRNCLH
     DGGFLRQLYT IGLLAQFESL LSTYGEELAM LEDMSLGIMD LRNVTFKVTQ ATSNASSDML
     PVITGNRDGF NVRIPLPGPL FDSLPREIQS GMLLRVQPVL FNVGINEQQT LAERFGDTSL
     QEVINVESLV RLNSYFEQFK EVLPEDCLPR SRSQTCLPEL LRFLGQNVHA RKNKNVDILW
     QAAEVCRRLN GVRFTSCKSA KDRTAMSVTL EQCLILQHEH GMAPQVFTQA LECMRSEGCR
     RENTMKNVGS RKYAFNSLQL KAFPKHYRPP EGTYGKVET
//
